Rhythm Pharmaceuticals buy UBS Group AG
Start price
17.12.25
/
50%
€95.50
Target price
17.12.26
-
Performance (%)
-3.14%
Price
02.02.26
€84.50
Summary
This prediction is currently active. With a performance of -3.14%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 17.12.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -2.874% | -2.874% |
| iShares Core DAX® | -0.436% | 1.181% |
| iShares Nasdaq 100 | 0.854% | 1.475% |
| iShares Nikkei 225® | 2.652% | 6.401% |
| iShares S&P 500 | 1.190% | 1.169% |
Comments by UBS_Group_AG for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for RYTM provided by MarketBeat